Pembrolizumab biosimilar
Published date: 2023-04-03 13:24:48
|
Name | Pembrolizumab | CAS# | 1374853-91-4 |
|---|---|---|---|---|
| Price | $Inquiry/100mg $Inquiry/500mg $Inquiry/1g $Inquiry/2g | Purity | 98.0% | |
| Stocking Period |
Inquiry | Stock | In Stock |
| Detail
Product Information
Pembrolizumab biosimilar is a humanized monoclonal antibody that blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2. It is an IgG4 kappa immunoglobulin with an approximate molecular weight of 149 kDa. Pembrolizumab biosimilar is supplied at a concentration of 25 mg/mL as a sterile, preservative-free, clear to slightly opalescent, colorless to slightly yellow solution, which contains 1.55 mg/mL L-histidine, 0.2 mg/mL polysorbate 80, 70 mg/mL sucrose, and Water for Injection. Statement: this product is used for R&D only, not for clinical usage. |